Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Jun 15, 2023; 15(6): 1073-1085
Published online Jun 15, 2023. doi: 10.4251/wjgo.v15.i6.1073
Table 2 Association of computed tomography features and malignant potential in patients with gastric gastrointestinal stromal tumors
Factor
Low risk group (n = 101)
High risk group (n = 46)
χ2
P value
Location0.5480.76
Fundus55 (54.5)28 (60.9)
Body35 (34.7)14 (30.4)
Antrum11 (10.9)4 (8.7)
Tumor diameter (cm)164.928< 0.001
> 10 cm1 (1.0)7 (15.2)
5-10 cm2 (2.0)21 (45.7)
≤ 5 cm98 (97.0)18 (39.1)
Tumor contours28.42< 0.001
Irregular3 (3.0)16 (34.8)
Regular98 (97.0)30 (65.2)
Ulceration9.1610.002
Present25 (24.8)23 (50.0)
Absent76 (75.2)23 (50.0)
Cystic degeneration or necrosis23.3< 0.001
Present45 (44.6)40 (87.0)
Absent56 (55.4)6 (13.0)
Calcification0.3090.578
Present14 (13.9)8 (17.4)
Absent87 (86.1)38 (82.6)
Growth patterns14.6340.001
Mixed8 (7.9)13 (28.3)
Endoluminal69 (68.3)18 (39.1)
Exophytic24 (23.8)15 (32.6)
Lymphadenopathy5.6270.018
Present19 (18.8)17 (37.0)
Absent82 (81.2)29 (63.0)
Enhancement pattern28.192< 0.001
Heterogeneous51 (50.5)44 (95.7)
Homogenous50 (49.5)2 (4.3)
Enhancement degree5.1880.075
Marked12 (11.9)10 (21.7)
Moderate83 (82.2)30 (65.2)
Mild6 (5.9)6 (13.0)